Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Oligodendrocyte transcription factor 2 (Oligo2) (Class B basic helix-loop-helix protein 1) (bHLHb1) (Class E basic helix-loop-helix protein 19) (bHLHe19) (Protein kinase C-binding protein 2) (Protein kinase C-binding protein RACK17)

 OLIG2_HUMAN             Reviewed;         323 AA.
Q13516; B3KRF3; Q05BP9; Q49AL3; Q86X04; Q9NZ14;
30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
13-AUG-2002, sequence version 2.
25-OCT-2017, entry version 147.
RecName: Full=Oligodendrocyte transcription factor 2;
Short=Oligo2;
AltName: Full=Class B basic helix-loop-helix protein 1;
Short=bHLHb1;
AltName: Full=Class E basic helix-loop-helix protein 19;
Short=bHLHe19;
AltName: Full=Protein kinase C-binding protein 2;
AltName: Full=Protein kinase C-binding protein RACK17;
Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Hippocampus;
Kuroda S., Tokunaga C., Kiyohara Y., Konishi H., Kikkawa U.;
"Protein kinase C-binding protein.";
Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION.
PubMed=10737801; DOI=10.1073/pnas.97.7.3497;
Wang J., Jani-Sait S.N., Escalon E.A., Carroll A.J., de Jong P.J.,
Kirsch I.R., Aplan P.D.;
"The t(14;21)(q11.2;q22) chromosomal translocation associated with T-
cell acute lymphoblastic leukemia activates the BHLHB1 gene.";
Proc. Natl. Acad. Sci. U.S.A. 97:3497-3502(2000).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
TISSUE SPECIFICITY.
PubMed=11498220; DOI=10.1016/S0140-6736(01)05499-X;
Marie Y., Sanson M., Mokhtari K., Leuraud P., Kujas M.,
Delattre J.-Y., Poirier J., Zalc B., Hoang-Xuan K.;
"OLIG2 as a specific marker of oligodendroglial tumour cells.";
Lancet 358:298-300(2001).
[6]
TISSUE SPECIFICITY.
PubMed=11526205; DOI=10.1073/pnas.181340798;
Lu Q.R., Park J.K., Noll E., Chan J.A., Alberta J.A., Yuk D.-I.,
Alzamora M.G., Louis D.N., Stiles C.D., Rowitch D.H., Black P.M.;
"Oligodendrocyte lineage genes (OLIG) as molecular markers for human
glial brain tumors.";
Proc. Natl. Acad. Sci. U.S.A. 98:10851-10856(2001).
-!- FUNCTION: Required for oligodendrocyte and motor neuron
specification in the spinal cord, as well as for the development
of somatic motor neurons in the hindbrain. Cooperates with OLIG1
to establish the pMN domain of the embryonic neural tube.
Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron
development (By similarity). {ECO:0000250}.
-!- SUBUNIT: Interacts with NKX2-2. {ECO:0000250}.
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
ProRule:PRU00981}. Cytoplasm {ECO:0000250}. Note=The NLS contained
in the bHLH domain could be masked in the native form and
translocation to the nucleus could be mediated by interaction
either with class E bHLH partner protein or with NKX2-2.
{ECO:0000250}.
-!- TISSUE SPECIFICITY: Expressed in the brain, in oligodendrocytes.
Strongly expressed in oligodendrogliomas, while expression is weak
to moderate in astrocytomas. Expression in glioblastomas highly
variable. {ECO:0000269|PubMed:11498220,
ECO:0000269|PubMed:11526205}.
-!- INDUCTION: By SHH. Also induced by NKX6-1 in the developing spinal
cord, but not in the rostral hindbrain (By similarity).
{ECO:0000250}.
-!- DOMAIN: The bHLH is essential for interaction with NKX2-2.
{ECO:0000250}.
-!- DISEASE: Note=A chromosomal aberration involving OLIG2 may be a
cause of a form of T-cell acute lymphoblastic leukemia (T-ALL).
Translocation t(14;21)(q11.2;q22) with TCRA.
{ECO:0000269|PubMed:10737801}.
-!- SEQUENCE CAUTION:
Sequence=AAC72247.1; Type=Erroneous initiation; Evidence={ECO:0000305};
Sequence=AAF61215.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/OLIG2ID236.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U48250; AAC72247.1; ALT_INIT; mRNA.
EMBL; AF221520; AAF61215.1; ALT_INIT; mRNA.
EMBL; AK091462; BAG52365.1; -; mRNA.
EMBL; BC034681; AAH34681.1; -; mRNA.
EMBL; BC036245; AAH36245.1; -; mRNA.
EMBL; BC047511; AAH47511.1; -; mRNA.
CCDS; CCDS13620.1; -.
PIR; G02409; G02409.
RefSeq; NP_005797.1; NM_005806.3.
RefSeq; XP_005260965.1; XM_005260908.1.
UniGene; Hs.176977; -.
UniGene; Hs.732068; -.
ProteinModelPortal; Q13516; -.
SMR; Q13516; -.
BioGrid; 115510; 3.
IntAct; Q13516; 3.
STRING; 9606.ENSP00000331040; -.
iPTMnet; Q13516; -.
PhosphoSitePlus; Q13516; -.
BioMuta; OLIG2; -.
DMDM; 22261817; -.
EPD; Q13516; -.
PaxDb; Q13516; -.
PRIDE; Q13516; -.
Ensembl; ENST00000333337; ENSP00000331040; ENSG00000205927.
Ensembl; ENST00000382357; ENSP00000371794; ENSG00000205927.
GeneID; 10215; -.
KEGG; hsa:10215; -.
UCSC; uc002yqx.3; human.
CTD; 10215; -.
DisGeNET; 10215; -.
EuPathDB; HostDB:ENSG00000205927.4; -.
GeneCards; OLIG2; -.
H-InvDB; HIX0016071; -.
HGNC; HGNC:9398; OLIG2.
HPA; CAB019381; -.
HPA; HPA003254; -.
MIM; 606386; gene.
neXtProt; NX_Q13516; -.
OpenTargets; ENSG00000205927; -.
PharmGKB; PA31919; -.
eggNOG; KOG3898; Eukaryota.
eggNOG; ENOG411169H; LUCA.
GeneTree; ENSGT00530000063239; -.
HOGENOM; HOG000015765; -.
HOVERGEN; HBG053370; -.
InParanoid; Q13516; -.
KO; K09085; -.
OMA; SFQHWGG; -.
OrthoDB; EOG091G129L; -.
PhylomeDB; Q13516; -.
TreeFam; TF322733; -.
SIGNOR; Q13516; -.
GeneWiki; OLIG2; -.
GenomeRNAi; 10215; -.
PRO; PR:Q13516; -.
Proteomes; UP000005640; Chromosome 21.
Bgee; ENSG00000205927; -.
CleanEx; HS_OLIG2; -.
ExpressionAtlas; Q13516; baseline and differential.
Genevisible; Q13516; HS.
GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
GO; GO:0042552; P:myelination; IEA:Ensembl.
GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl.
GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
GO; GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl.
GO; GO:0021794; P:thalamus development; IEA:Ensembl.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
CDD; cd00083; HLH; 1.
Gene3D; 4.10.280.10; -; 1.
InterPro; IPR011598; bHLH_dom.
InterPro; IPR036638; HLH_DNA-bd_sf.
InterPro; IPR032658; Olig2.
PANTHER; PTHR19290:SF32; PTHR19290:SF32; 1.
Pfam; PF00010; HLH; 1.
SMART; SM00353; HLH; 1.
SUPFAM; SSF47459; SSF47459; 1.
PROSITE; PS50888; BHLH; 1.
2: Evidence at transcript level;
Chromosomal rearrangement; Complete proteome; Cytoplasm;
Developmental protein; DNA-binding; Nucleus; Proto-oncogene;
Reference proteome; Transcription; Transcription regulation.
CHAIN 1 323 Oligodendrocyte transcription factor 2.
/FTId=PRO_0000127414.
DOMAIN 108 162 bHLH. {ECO:0000255|PROSITE-
ProRule:PRU00981}.
COMPBIAS 77 88 Poly-Ser.
COMPBIAS 206 212 Poly-Ala.
COMPBIAS 225 237 Poly-Ala.
COMPBIAS 266 270 Poly-Ala.
COMPBIAS 273 280 Poly-Gly.
CONFLICT 67 67 G -> V (in Ref. 3; AAH36245).
{ECO:0000305}.
CONFLICT 150 150 A -> T (in Ref. 4; AAH47511).
{ECO:0000305}.
SEQUENCE 323 AA; 32385 MW; 0EC9223961062509 CRC64;
MDSDASLVSS RPSSPEPDDL FLPARSKGSS GSAFTGGTVS SSTPSDCPPE LSAELRGAMG
SAGAHPGDKL GGSGFKSSSS STSSSTSSAA ASSTKKDKKQ MTEPELQQLR LKINSRERKR
MHDLNIAMDG LREVMPYAHG PSVRKLSKIA TLLLARNYIL MLTNSLEEMK RLVSEIYGGH
HAGFHPSACG GLAHSAPLPA ATAHPAAAAH AAHHPAVHHP ILPPAAAAAA AAAAAAAVSS
ASLPGSGLPS VGSIRPPHGL LKSPSAAAAA PLGGGGGGSG ASGGFQHWGG MPCPCSMCQV
PPPHHHVSAM GAGSLPRLTS DAK


Related products :

Catalog number Product name Quantity
EIAAB28826 bHLHb1,BHLHB1,bHLHe19,BHLHE19,Class B basic helix-loop-helix protein 1,Class E basic helix-loop-helix protein 19,Homo sapiens,Human,OLIG2,Oligo2,Oligodendrocyte transcription factor 2,PRKCBP2,Protein
18-003-43089 Oligodendrocyte transcription factor 2 - Oligo2; Basic helix-loop-helix protein class B 1; Protein kinase C-binding protein RACK17; Protein kinase C-binding protein 2 Polyclonal 0.05 mg Aff Pur
EIAAB37697 Basic helix-loop-helix transcription factor scleraxis,bHLHa41,BHLHA41,bHLHa48,Class A basic helix-loop-helix protein 41,Class A basic helix-loop-helix protein 48,Homo sapiens,Human,SCX,SCXA
EIAAB28828 bHLHb7,BHLHB7,bHLHe20,BHLHE20,Class B basic helix-loop-helix protein 7,Class E basic helix-loop-helix protein 20,Homo sapiens,Human,OLIG3,Oligo3,Oligodendrocyte transcription factor 3
EIAAB28821 bHLHb6,BHLHB6,bHLHe21,BHLHE21,Class B basic helix-loop-helix protein 6,Class E basic helix-loop-helix protein 21,Homo sapiens,Human,OLIG1,Oligo1,Oligodendrocyte transcription factor 1
U2004h CLIA Basic-helix-loop-helix-PAS protein MOP2,bHLHe73,BHLHE73,Class E basic helix-loop-helix protein 73,Endothelial PAS domain-containing protein 1,EPAS1,EPAS-1,HIF-1-alpha-like factor,HIF2A,HIF-2-alph 96T
E2004h ELISA Basic-helix-loop-helix-PAS protein MOP2,bHLHe73,BHLHE73,Class E basic helix-loop-helix protein 73,Endothelial PAS domain-containing protein 1,EPAS1,EPAS-1,HIF-1-alpha-like factor,HIF2A,HIF-2-alp 96T
U2004h CLIA kit Basic-helix-loop-helix-PAS protein MOP2,bHLHe73,BHLHE73,Class E basic helix-loop-helix protein 73,Endothelial PAS domain-containing protein 1,EPAS1,EPAS-1,HIF-1-alpha-like factor,HIF2A,HIF-2 96T
E2004h ELISA kit Basic-helix-loop-helix-PAS protein MOP2,bHLHe73,BHLHE73,Class E basic helix-loop-helix protein 73,Endothelial PAS domain-containing protein 1,EPAS1,EPAS-1,HIF-1-alpha-like factor,HIF2A,HIF- 96T
U0798h CLIA ARNT-interacting protein,Basic-helix-loop-helix-PAS protein MOP1,bHLHe78,BHLHE78,Class E basic helix-loop-helix protein 78,HIF1A,HIF-1-alpha,HIF1-alpha,Homo sapiens,Human,Hypoxia-inducible factor 96T
U0255h CLIA ATH1,ATOH1,bHLHa14,BHLHA14,Class A basic helix-loop-helix protein 14,hATH1,Helix-loop-helix protein hATH-1,Homo sapiens,Human,Protein atonal homolog 1 96T
E0255h ELISA kit ATH1,ATOH1,bHLHa14,BHLHA14,Class A basic helix-loop-helix protein 14,hATH1,Helix-loop-helix protein hATH-1,Homo sapiens,Human,Protein atonal homolog 1 96T
E0255h ELISA ATH1,ATOH1,bHLHa14,BHLHA14,Class A basic helix-loop-helix protein 14,hATH1,Helix-loop-helix protein hATH-1,Homo sapiens,Human,Protein atonal homolog 1 96T
E0798h ELISA ARNT-interacting protein,Basic-helix-loop-helix-PAS protein MOP1,bHLHe78,BHLHE78,Class E basic helix-loop-helix protein 78,HIF1A,HIF-1-alpha,HIF1-alpha,Homo sapiens,Human,Hypoxia-inducible facto 96T
E0798h ELISA kit ARNT-interacting protein,Basic-helix-loop-helix-PAS protein MOP1,bHLHe78,BHLHE78,Class E basic helix-loop-helix protein 78,HIF1A,HIF-1-alpha,HIF1-alpha,Homo sapiens,Human,Hypoxia-inducible 96T
EIAAB14718 Basic helix-loop-helix protein N-twist,bHLHa31,BHLHA31,Class A basic helix-loop-helix protein 31,Fer3-like protein,FERD3L,Homo sapiens,Human,NATO3,Nephew of atonal 3,Neuronal twist,NTWIST
EIAAB27132 bHLHa6,BHLHA6,Class A basic helix-loop-helix protein 6,Homo sapiens,Human,NeuroD3,NEUROD3,NEUROG1,Neurogenic basic-helix-loop-helix protein,Neurogenic differentiation factor 3,Neurogenin-1,NGN,NGN1,NG
EIAAB27618 Basic-helix-loop-helix-PAS protein MOP6,bHLHe12,BHLHE12,Class E basic helix-loop-helix protein 12,Homo sapiens,Human,Member of PAS protein 6,MOP6,Neuronal PAS domain-containing protein 3,Neuronal PAS3
EIAAB27615 Basic-helix-loop-helix-PAS protein MOP4,bHLHe9,BHLHE9,Class E basic helix-loop-helix protein 9,Homo sapiens,Human,Member of PAS protein 4,MOP4,Neuronal PAS domain-containing protein 2,Neuronal PAS2,NP
EIAAB27612 Basic-helix-loop-helix-PAS protein MOP5,bHLHe11,BHLHE11,Class E basic helix-loop-helix protein 11,Homo sapiens,Human,Member of PAS protein 5,MOP5,Neuronal PAS domain-containing protein 1,Neuronal PAS1
EIAAB42085 Activating enhancer-binding protein 4,bHLHc41,BHLHC41,Class C basic helix-loop-helix protein 41,Homo sapiens,Human,TFAP4,Transcription factor AP-4
EIAAB24971 bHLHd13,BHLHD13,Class D basic helix-loop-helix protein 13,Homo sapiens,Human,Max-like bHLHZip protein,Max-like protein X,MLX,Protein BigMax,TCFL4,Transcription factor-like protein 4
EIAAB24976 bHLHd14,Carbohydrate-responsive element-binding protein,ChREBP,Class D basic helix-loop-helix protein 14,MLX interactor,MLX-interacting protein-like,Mlxipl,Rat,Rattus norvegicus,Wbscr14,Williams-Beure
EIAAB27130 Ath4c,Helix-loop-helix protein mATH-4C,mATH4C,Mouse,Mus musculus,NeuroD3,Neurod3,Neurog1,Neurogenic basic-helix-loop-helix protein,Neurogenic differentiation factor 3,Neurogenin-1,Ngn,Ngn1,NGN-1
EIAAB25052 bHLHd3,BHLHD3,Class D basic helix-loop-helix protein 3,Homo sapiens,Human,Max-binding protein MNT,MNT,Myc antagonist MNT,Protein ROX,ROX


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur